Search

You searched for "VUR"

377 results found

Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder

7 January 2021 | | Urologic Oncology
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...

From female genital mutilation to female genital reconstruction

10 June 2019 | Research & Development
The demand for reconstruction of mutilated female genitalia is increasing in Europe due to the empowerment of immigrant and naturalised women from Africa. Their wish for reconstruction is more than a matter of surgery, as these women...

Junior doctors’ strike: is there light at the end of the tunnel?

1 July 2016 | | Trauma and Emergency Urology
Most urology departments will be affected one way or another by the ongoing industrial action by our junior colleagues. This article gives an interview between the BMJ team and Jeremy Hunt, UK Secretary of State for Health. We may or...

In conversation with Veeru Kasivisvanathan at BAUS 2019

9 October 2019 |
We chat to Veeru Kasivisvanathan, Urology Specialist Registrar and Chair of BURST. Click the image below to see his answers to our questions.

In conversation with Asif Muneer at BAUS 2019

9 October 2019 |
We chat to Asif Muneer, Consultant Urological Surgeon and BAUS Honorary Secretary Elect. Click the image below to see his answers to our questions.

In conversation with Jane Brocksom at BAUS 2019

9 October 2019
We chat to Jane Brocksom, President of BAUN (British Association of Urological Nurses) at BAUS 2019 Click the image below to see his answers to our questions.

In conversation with Ben Challacombe at BAUS 2019

9 October 2019 |
We catch up with Ben Challacombe, Consultant Urological Surgeon, Guy’s and St Thomas’s, London at BAUS 2019. Click the image below to see his answers to our questions.

Keep patients at the heart of treatment decision

30 September 2022
Rebecca Porta, Chief Executive of The Urology Foundation, and Chris Whitehouse, Chair of the Urology Trade Association, mark Urology Awareness Month. Rebecca Porta Chris Whitehouse Keep patients at the heart of treatment decision This September marked Urology Awareness Month (UAM),...

The management of renal calculi – Pt 1

1 March 2018 | | Endourology and Stones
Renal calculi can be managed according to four treatment options: conservative management, extracorporeal shockwave lithotripsy (ESWL), flexible ureterorenoscopy (FURS) and percutaneous nephrolithotomy (PCNL). This is the first in a two-part series in Urology News (Part 2 available here) that will...

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

3 September 2021 | | Urologic Oncology
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

Small renal masses – diagnosis and management

1 January 2017 | | Urologic Oncology
Renal cancer is the eighth most common cancer in the UK and accounts for about 3% of all new cancer diagnoses [1]. The incidence rates are steadily rising, with the highest rates being in older men and women. This rise...

Renal calculi composition – Hounsfield units or dual energy CT?

1 July 2014 | | Endourology and Stones, Uroradiology
In this, the inaugural uro-radiology article, Jane Belfield (Section Editor) considers the significance of Hounsfield units in defining stone composition. Despite its widespread adoption and referencing in stone MDTs, there are some very clear limitations. Jane explores the potential role...